WEXFORD CAPITAL LP - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.

Quarter-by-quarter ownership
WEXFORD CAPITAL LP ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q3 2016$498,000
+67.1%
4,000
+28.2%
0.08%
-6.9%
Q1 2015$298,000
-29.0%
3,120
-74.2%
0.09%
+171.9%
Q1 2014$420,000
+20.3%
12,1000.0%0.03%
+6.7%
Q4 2013$349,00012,1000.03%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q4 2016
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 8,344,200$960,918,0007.67%
RUDMAN ERROL M 130,201$14,994,0005.06%
Ativo Capital Management LLC 59,101$7,258,0002.56%
Kylin Management 188,226$21,676,0002.36%
Monashee Investment Management LLC 40,000$4,606,0002.17%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 62,866$7,240,0001.91%
Cormorant Asset Management, LP 111,500$12,840,0001.71%
OBERWEIS ASSET MANAGEMENT INC/ 53,500$6,161,0001.63%
Perceptive Advisors 147,604$16,998,0001.02%
Granite Point Capital Management, L.P. 29,160$3,358,0000.98%
View complete list of CHINA BIOLOGIC PRODS INC shareholders